Front pages with contents of No. 57, 1996

Front cover. Contents.

Back pages of No. 57, 1996

Charles Darwin Foundation for the Galapagos Islands. Map

Eficiência de fungicidas para o controle da ferrugem asiática da soja em Londrina e Tamarana, PR, na safra 2007/08.

2008

Atlas" vodânogo soobŝenìâ meždu gorodom" Tamerforsom" i Kirhšpilem" Virdojs" = Kartasto osoittava vesimatkat Tampereen kaupungin ja Wirtain pitäjän välillä, toimitettu vuosina 1856, 57 ja 58 sotalaivaston perämiesosaston upsierien Näsijärven vesillä tekemäin mittausten mukaan

Kansinimeke: Näsijärven Walta-Kartta

Estadística de la enseñanza universitaria española durante el curso 1956-57.

Estudio estadístico en el que se exponen algunas características de la población escolar universitaria y se analizan varios aspectos que comprende, presentándolos aisladamente o en conexión entre sí, para ver la influencia que experimentan sus datos. Las cifras desvelaban que el mayor número de matriculados se encontraban en Derecho y Medicina. En cuanto a las mujeres, se decantaban más por Farmacia y Filosofía y Letras. En cuanto a los alumnos universitarios clasificados por el lugar de residencia de sus padres, se desprende que, en aquellas provincias cabeza de Distrito Universitario, favorecen la existencia de mayor número de alumnos universitarios. Para terminar, un último gráfico desvela que un tercio de los alumnos de enseñanza superior son titulados universitarios, por lo que resulta un condicionante importante para estos alumnos.

Unesp Informa, 2014, número 57

Boletim elaborado pela Assessoria de Comunicação e Imprensa da Reitoria da UNESP

Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07)

The EGF receptor (EGFR) is overexpressed in the majority of metastatic castration-resistant prostate cancers (mCRPC) and might represent a valid therapeutic target. The combination of docetaxel and cetuximab, the monoclonal antibody against EGFR, has not been tested in patients with prostate cancer.

Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)

INTRODUCTION Small-cell lung cancer (SCLC) is a highly vascularized tumor. ASA404 is a tumor vascular disrupting agent. This is the first trial to report the effects of combining chemotherapy with ASA404 in SCLC. METHODS Patients with untreated metastatic SCLC were treated with carboplatin (area under curve, 6) plus paclitaxel (175 mg/m(2)) plus ASA404 (1800 mg/m(2)) on day 1 every 21 days for up to 6 cycles. The primary endpoint was the progression-free survival (PFS) rate at 24 weeks. RESULTS Median age was 61 years; 53% were women, 41% had weight loss; and 96% had a performance status of 0-1. Twelve patients completed all 6 cycles, and most adverse events were related to chemotherapy. Median PFS and time to progression were 7.0 months (95% CI, 5.7-9.4 months) and 7.5 months (95% CI, 5.7-9.4 months), respectively. The progression-free survival (PFS) rate at 24 weeks was 41% (95% CI, 18%-65%). The overall response rate was 94%. The median overall survival time was 14.2 months (95% CI, 8.2-16.0 months) and 1-year survival was 57%. The median follow-up time was 17.7 months. Due to negative results with ASA404 in non-small-cell lung cancer trials, the trial was stopped prematurely after 17 of 56 planned patients were being accrued. CONCLUSIONS This is the first report of a clinical trial with a vascular disrupting agent in SCLC. No unexpected toxicity was observed. PFS was not prolonged with carboplatin and paclitaxel plus ASA404.

Na 1 Nachlass Max Horkheimer, 57 - Korrespondenzen u.a. mit Hilde Weiss (p. I 27, 1-185)

1 Brief von Max Horkheimer an Weiss, 18.07.1937; 27 Briefe und Beilagen zwischen Hilde Weiss und Max Horkheimer, 1934-1936, 1945 sowie Briefwechsel mit der Commission on Community Interrelations of the American Jewish Congress; 3 Briefe zwischen der Commission on Community Interrelations of the American Jewish Congress und Max Horkheimer, 02.10.1945, 1945; 2 Briefe und Beilage zwischen dem Social Science Research Council und Max Horkheimer, 04.02.1943, 18.03.1943; 1 Brief und 1 Beilage von Leo Löwenthal an Margot von Mendelssohn, 01.03.1943; 2 Briefe zwischen Ernst Weissmann und Max Horkheimer, 07.09.1945; 11 Briefe zwischen Leo H. Weissmann und Max Horkheimer, 1938-1939; 1 Brief von Max Horkheimer an Chaim Weizmann, 06.05.1941; 8 Briefe und 1 Beilage zwischen Karl Georg Wendriner, Anna Wendriner und Max Horkheimer, 1935-1938; 1 Brief von Max Horkheimer an Frederic Wertham, 18.11.1941; 2 Briefe zwischen Wertheimer und Max Horkheimer, 07.11.1934; 2 Briefe von Abr. F. Westermann an Max Horkheimer, 1932, 1934; 1 Brief von Max Horkheimer an die Western Service Corporation, 06.04.1941; 30 Briefe zwischen Wetzel und Max Horkheimer, 1937-1939; 3 Briefe zwischen Helen B. White und Max Horkheimer, 16.03.1939, 1939; 3 Briefe zwischen John Whyte und Max Horkheimer, 01.03.1941, 12.03.1941; 3 Briefe und 1 Beilage zwischen Philip Paul Wiener und Max Horkheimer, 08.12.1938, 1938; 7 Briefe zwischen Maria Wiesengrund und Max Horkheimer, 1942, 1945, 1948; 1 Lebenslauf und 2 Zeugnisse von Ilse Wiesenthal; 1 Brief vom Comité International Pour Le Placement Des Intellectuels Réfugiés an Max Horkheimer in Verbindung mit Ilse Wiesenthal, Dezember 1935; 1 Brief von Max Horkheimer an Willen; 1 Brief vom The Wimbledon Co Master Tailors an Max Horkheimer, 15.06.1937; 5 Briefe zwischen Josef Winternitz und Max Horkheimer, 1938-1939; 7 Briefe zwischen Louis Wirth und Max Horkheimer, 1937-1941; 22 Briefe zwischen Egon Wissing und Max Horkheimer, 1936-1941 sowie Briefwechsel mit dem Georg Washington Hotel, New York; 1 Brief von Lieselotte Karplen an Maidon Horkheimer, 25.04.1940; 2 Briefe zwischen dem Georg Washington Hotel und Max Horkheimer, 07.05.1936, 12.05.1936;